Published in Infect Immun on October 01, 1988
Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev (1998) 13.09
Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev (1991) 7.11
Virulence patterns and long-range genetic mapping of extraintestinal Escherichia coli K1, K5, and K100 isolates: use of pulsed-field gel electrophoresis. Infect Immun (1991) 2.02
Adherence to respiratory epithelia by recombinant Escherichia coli expressing Klebsiella pneumoniae type 3 fimbrial gene products. Infect Immun (1992) 1.71
Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection. Infect Immun (2012) 1.53
Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect Immun (2005) 1.32
Cloning and characterization of the S fimbrial adhesin II complex of an Escherichia coli O18:K1 meningitis isolate. Infect Immun (1993) 1.31
Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Infect Immun (1990) 1.28
Binding of the type 3 fimbriae of Klebsiella pneumoniae to human endothelial and urinary bladder cells. Infect Immun (1997) 1.26
Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun (1992) 1.25
Adhesive threads of extraintestinal pathogenic Escherichia coli. Gut Pathog (2009) 1.24
Genetically engineered S and F1C fimbriae differ in their contribution to adherence of Escherichia coli to cultured renal tubular cells. Infect Immun (1990) 1.23
Reciprocal exchange of minor components of type 1 and F1C fimbriae results in hybrid organelles with changed receptor specificities. J Bacteriol (1994) 1.23
Osmolarity and pH growth conditions regulate fim gene transcription and type 1 pilus expression in uropathogenic Escherichia coli. Infect Immun (2002) 1.21
Receptor structure for F1C fimbriae of uropathogenic Escherichia coli. Infect Immun (2000) 1.20
F1C fimbriae of a uropathogenic Escherichia coli strain: genetic and functional organization of the foc gene cluster and identification of minor subunits. J Bacteriol (1990) 1.18
Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins. Infect Immun (1988) 1.15
Sialyloligosaccharide chains of laminin as an extracellular matrix target for S fimbriae of Escherichia coli. Infect Immun (1993) 1.07
Purified P fimbriae from two cloned gene clusters of a single pyelonephritogenic strain adhere to unique structures in the human kidney. Infect Immun (1989) 1.06
Use of a wild-type gene fusion to determine the influence of environmental conditions on expression of the S fimbrial adhesin in an Escherichia coli pathogen. J Bacteriol (1990) 1.00
The export systems of type 1 and F1C fimbriae are interchangeable but work in parental pairs. J Bacteriol (1995) 0.98
Regulatory Interactions among adhesin gene systems of uropathogenic Escherichia coli. Infect Immun (2007) 0.96
Inhibition of adherence of multi-drug resistant E. coli by proanthocyanidin. Urol Res (2011) 0.90
Pathogenicity of an Escherichia coli O115:K"V165" mutant negative for F165(1) fimbriae in septicemia of gnotobiotic pigs. Infect Immun (1993) 0.90
The cellular form of human fibronectin as an adhesion target for the S fimbriae of meningitis-associated Escherichia coli. Infect Immun (1999) 0.84
Pyelonephritogenic diffusely adhering Escherichia coli EC7372 harboring Dr-II adhesin carries classical uropathogenic virulence genes and promotes cell lysis and apoptosis in polarized epithelial caco-2/TC7 cells. Infect Immun (2000) 0.83
Regulation of fim genes in uropathogenic Escherichia coli. World J Clin Infect Dis (2011) 0.83
OmpR regulation of the uropathogenic Escherichia coli fimB gene in an acidic/high osmolality environment. Microbiology (2012) 0.82
Purification and characterization of the Dr hemagglutinins expressed by two uropathogenic Escherichia coli strains. Infect Immun (1990) 0.81
Oral consumption of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli. J Med Food (2011) 0.81
Influence of fluoroquinolones on expression and function of P fimbriae in uropathogenic Escherichia coli. Antimicrob Agents Chemother (1989) 0.78
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr (2016) 0.77
Purification, crystallization and preliminary data analysis of FocB, a transcription factor regulating fimbrial adhesin expression in uropathogenic Escherichia coli. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.75
A complementation analysis of the restriction and modification of DNA in Escherichia coli. J Mol Biol (1969) 71.21
The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J (1959) 31.27
Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun (1983) 14.71
Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet (1976) 7.15
Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun (1981) 5.24
Comparison of Escherichia coli fimbrial antigen F7 with type 1 fimbriae. Infect Immun (1980) 5.19
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10
Inhibition of the interaction between fimbrial haemagglutinins and erythrocytes by D-mannose and other carbohydrates. J Gen Microbiol (1972) 4.97
Genes of pyelonephritogenic E. coli required for digalactoside-specific agglutination of human cells. EMBO J (1984) 4.22
Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun (1985) 4.01
Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. J Infect Dis (1979) 3.82
Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells. Infect Immun (1981) 3.72
Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain. Infect Immun (1985) 3.58
P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun (1984) 3.50
Effect of pili on susceptibility of Escherichia coli to phagocytosis. Infect Immun (1979) 3.24
Escherichia coli fimbriae recognizing sialyl galactosides. J Bacteriol (1984) 3.16
Serology of Escherichia coli fimbriae. Prog Allergy (1983) 3.11
Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J Clin Invest (1985) 2.97
Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili. Infect Immun (1982) 2.39
Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71. J Bacteriol (1984) 2.11
Fimbria-like hemagglutinin of Escherichia coli O75 strains. Infect Immun (1984) 2.07
Prevention of pyelonephritis by immunization with P-fimbriae. J Urol (1984) 1.85
Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest (1988) 1.82
Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli. Infect Immun (1986) 1.77
Identification of two new hemagglutinins of Escherichia coli, N-acetyl-D-glucosamine-specific fimbriae and a blood group M-specific agglutinin, by cloning the corresponding genes in Escherichia coli K-12. J Bacteriol (1986) 1.74
Location of adhesion sites for P-fimbriated and for 075X-positive Escherichia coli in the human kidney. Microb Pathog (1986) 1.69
Binding specificity of piliated strains of Escherichia coli and Salmonella typhimurium to epithelial cells, saccharomyces cerevisiae cells, and erythrocytes. Infect Immun (1981) 1.68
Identification of a carbohydrate receptor recognized by uropathogenic Escherichia coli. Infection (1980) 1.66
Occurrence of type-1C fimbriae on Escherichia coli strains isolated from human extraintestinal infections. J Gen Microbiol (1985) 1.53
Binding of Escherichia coli S fimbriae to human kidney epithelium. Infect Immun (1986) 1.46
Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest (1981) 1.45
Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J Infect Dis (1987) 1.44
P fimbriae and other virulence factors in Escherichia coli urosepsis: association with patients' characteristics. J Infect Dis (1987) 1.43
Fimbrial phase variation and systemic E. coli infection studied in the mouse peritonitis model. Microb Pathog (1986) 1.40
Localization of binding sites for purified Escherichia coli P fimbriae in the human kidney. Infect Immun (1986) 1.39
Analysis of P fimbriae on Escherichia coli O2, O4, and O6 strains by immunoprecipitation. Infect Immun (1986) 1.21
Lectin binding sites in kidney. A comparative study of 14 animal species. J Histochem Cytochem (1983) 1.14
Isolation and structural characterization of five major sialyloligosaccharides and a sialylglycopeptide from normal human urine. Eur J Biochem (1983) 1.13
In vitro segregation of the metanephric nephron. Dev Biol (1981) 1.09
Phagolysosome formation by polymorphonuclear neutrophilic leukocytes after ingestion of Escherichia coli that express type 1 pili. J Infect Dis (1987) 1.09
Heterogeneous distribution of glycoconjugates in human kidney tubules. Anat Rec (1985) 1.07
The specific glycosphingolipid composition of human ureteral epithelial cells. J Biochem (1985) 1.01
The O75X adhesin of uropathogenic Escherichia coli: receptor-active domains in the canine urinary tract and in-vitro interaction with laminin. Microb Pathog (1987) 0.97
Cellular heterogeneity in normal human urothelium: quantitative studies of lectin binding. Histochem J (1987) 0.84
Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun (1981) 5.24
New Method for isolation of immunologically pure pili from Escherichia coli. Infect Immun (1980) 4.98
Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun (1985) 4.01
Genetic relationships and clonal structure of strains of Escherichia coli causing neonatal septicemia and meningitis. Infect Immun (1986) 3.57
P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun (1984) 3.50
Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest (1982) 3.29
Escherichia coli fimbriae recognizing sialyl galactosides. J Bacteriol (1984) 3.16
P-antigen-recognizing fimbriae from human uropathogenic Escherichia coli strains. Infect Immun (1982) 3.02
Escherichia coli strains binding neuraminyl alpha 2-3 galactosides. Biochem Biophys Res Commun (1983) 2.87
Bacterial proteins binding to the mammalian extracellular matrix. Mol Microbiol (1993) 2.81
Identification of the O-linked sialyloligosaccharides of glycophorin A as the erythrocyte receptors for S-fimbriated Escherichia coli. Infect Immun (1986) 2.62
Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli. Lancet (1982) 2.56
Clonal analysis of Escherichia coli O2:K1 isolated from diseased humans and animals. Infect Immun (1986) 2.27
Bacterial plasminogen activators and receptors. FEMS Microbiol Rev (2001) 2.19
Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica. Mol Microbiol (1993) 2.13
Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71. J Bacteriol (1984) 2.11
Aspects on structure and function of pili on uropathogenic Escherichia coli. Prog Allergy (1983) 2.11
Image processing for the study of brain structure and function: problems and programs. J Neuropsychiatry Clin Neurosci (1992) 1.97
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol (1990) 1.94
Characterization of type 1 pili of Salmonella typhimurium LT2. J Bacteriol (1980) 1.94
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol (2000) 1.93
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87
Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest (1988) 1.82
Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest (1983) 1.82
Type 3 fimbriae of Klebsiella sp.: molecular characterization and role in bacterial adhesion to plant roots. J Bacteriol (1983) 1.79
Expression of plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix. Infect Immun (1998) 1.76
Identification of two new hemagglutinins of Escherichia coli, N-acetyl-D-glucosamine-specific fimbriae and a blood group M-specific agglutinin, by cloning the corresponding genes in Escherichia coli K-12. J Bacteriol (1986) 1.74
Location of adhesion sites for P-fimbriated and for 075X-positive Escherichia coli in the human kidney. Microb Pathog (1986) 1.69
Binding specificity of piliated strains of Escherichia coli and Salmonella typhimurium to epithelial cells, saccharomyces cerevisiae cells, and erythrocytes. Infect Immun (1981) 1.68
Basement membrane carbohydrate as a target for bacterial adhesion: binding of type I fimbriae of Salmonella enterica and Escherichia coli to laminin. Mol Microbiol (1993) 1.66
Familial congenital diaphragmatic defects: aspects of etiology, prenatal diagnosis, and treatment. Am J Med Genet (1984) 1.61
Aerobactin-mediated iron uptake by Escherichia coli isolates from human extraintestinal infections. Infect Immun (1986) 1.60
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res (1998) 1.59
P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors. Infection (1983) 1.57
Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest (1984) 1.56
Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol (1996) 1.55
Occurrence of type-1C fimbriae on Escherichia coli strains isolated from human extraintestinal infections. J Gen Microbiol (1985) 1.53
Inhibition of pyridoxal enzymes by L-canaline. Biochim Biophys Acta (1971) 1.50
Analysis of the genetic determinants coding for the S-fimbrial adhesin (sfa) in different Escherichia coli strains causing meningitis or urinary tract infections. Infect Immun (1986) 1.48
Binding of Escherichia coli S fimbriae to human kidney epithelium. Infect Immun (1986) 1.46
Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest (1981) 1.45
Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J Infect Dis (1987) 1.44
Protein regions important for plasminogen activation and inactivation of alpha2-antiplasmin in the surface protease Pla of Yersinia pestis. Mol Microbiol (2001) 1.43
Characterization of the collagen-binding S-layer protein CbsA of Lactobacillus crispatus. J Bacteriol (2000) 1.43
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia (2002) 1.40
Fimbrial phase variation and systemic E. coli infection studied in the mouse peritonitis model. Microb Pathog (1986) 1.40
Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol (2001) 1.39
Localization of binding sites for purified Escherichia coli P fimbriae in the human kidney. Infect Immun (1986) 1.39
matB, a common fimbrillin gene of Escherichia coli, expressed in a genetically conserved, virulent clonal group. J Bacteriol (2001) 1.35
The type 3 fimbrial adhesin gene (mrkD) of Klebsiella species is not conserved among all fimbriate strains. Infect Immun (1994) 1.33
Cloning and characterization of the S fimbrial adhesin II complex of an Escherichia coli O18:K1 meningitis isolate. Infect Immun (1993) 1.31
Tissue tropism of Escherichia coli adhesins in human extraintestinal infections. Curr Top Microbiol Immunol (1990) 1.30
Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost (2000) 1.29
Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Infect Immun (1990) 1.28
A Collagen-Binding S-Layer Protein in Lactobacillus crispatus. Appl Environ Microbiol (1995) 1.27
Amino acid residue Ala-62 in the FimH fimbrial adhesin is critical for the adhesiveness of meningitis-associated Escherichia coli to collagens. Mol Microbiol (1999) 1.27
Binding of the type 3 fimbriae of Klebsiella pneumoniae to human endothelial and urinary bladder cells. Infect Immun (1997) 1.26
Novel cell-binding activity specific for N-acetyl-D-glucosamine in an Escherichia coli strain. FEBS Lett (1983) 1.25
Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun (1992) 1.25
Gastroschisis and omphalocele in Finland in the 1970s: prevalence at birth and its correlates. J Epidemiol Community Health (1982) 1.24
Analysis of P fimbriae on Escherichia coli O2, O4, and O6 strains by immunoprecipitation. Infect Immun (1986) 1.21
Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J (2001) 1.21
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer (1999) 1.21
The Pla surface protease/adhesin of Yersinia pestis mediates bacterial invasion into human endothelial cells. FEBS Lett (2001) 1.21
Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol (1999) 1.20
Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids. J Immunol (1996) 1.20
Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics (2011) 1.19
Outer Membrane Proteins and Lipopolysaccharides in Pathovars of Xanthomonas campestris. Appl Environ Microbiol (1993) 1.19
Susceptibility of human cells to Puumala virus infection. J Gen Virol (1993) 1.18
Characterization of the type 3 fimbrial adhesins of Klebsiella strains. Infect Immun (1998) 1.17
Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins. Infect Immun (1988) 1.15
Lectin binding sites in kidney. A comparative study of 14 animal species. J Histochem Cytochem (1983) 1.14
Characterization of the fimA gene encoding bundle-forming fimbriae of the plant pathogen Xanthomonas campestris pv. vesicatoria. J Bacteriol (1997) 1.14
Isolation and structural characterization of five major sialyloligosaccharides and a sialylglycopeptide from normal human urine. Eur J Biochem (1983) 1.13
Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix. Infect Immun (1995) 1.12
Interaction of Haemophilus influenzae with the mammalian extracellular matrix. J Infect Dis (1996) 1.11
Multifunctional role of choline binding protein G in pneumococcal pathogenesis. Infect Immun (2006) 1.11
Expression of pls, a gene closely associated with the mecA gene of methicillin-resistant Staphylococcus aureus, prevents bacterial adhesion in vitro. Infect Immun (2001) 1.11
Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest (2001) 1.11
A novel lectin-independent interaction of P fimbriae of Escherichia coli with immobilized fibronectin. FEBS Lett (1989) 1.10
Nephrin in experimental glomerular disease. Kidney Int (2000) 1.09
Type 1 fimbria-mediated adhesion of enteric bacteria to grass roots. Appl Environ Microbiol (1985) 1.09
Sialyloligosaccharide chains of laminin as an extracellular matrix target for S fimbriae of Escherichia coli. Infect Immun (1993) 1.07
Functional expression of adhesive peptides as fusions to Escherichia coli flagellin. Protein Eng (1997) 1.07
Podocalyxin in rat platelets and megakaryocytes. Am J Pathol (1999) 1.06
Fimbriation and P-antigen recognition of Escherichia coli strains harbouring mutated recombinant plasmids encoding fimbrial adhesins of the uropathogenic E. coli strain KS71. J Gen Microbiol (1986) 1.06